Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/17512433.2021.1961577 http://scihub22266oqcxt.onion/10.1080/17512433.2021.1961577 34328054!ä!34328054 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Expert+Rev+Clin+Pharmacol 2021 ; 14 (11): 1413-1425 Nephropedia Template TP {{tp|p=34328054|t=2021. Vaccination and their importance for lung transplant recipients in a COVID-19 world |pdf=|usr=}}{{34328054}} gab.com Text Vaccination and their importance for lung transplant recipients in a COVID-19 world JO: Expert Rev Clin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=34328054 #FOAvip INTRODUCTION: Lung transplant patients are immunocompromised because of the medication they receive to prevent rejection, and as a consequence are susceptible to (respiratory) infections. Adequate vaccination strategies, including COVID-19 vaccination, are therefore needed to minimize infection risks. AREAS COVERED: The international vaccination guidelines for lung transplant patients are reviewed, including the data on immunogenicity and effectivity of the vaccines. The impact on response to vaccination of the various categories of immunosuppressive drugs, used in the posttransplant period, on response to vaccination is described. A number of immunosuppressive and/or anti-inflammatory drugs also is used for controlling the immunopathology of severe COVID-19. Current available COVID-19 vaccines, both mRNA or adenovirus based are recommended for lung transplant patients. EXPERT OPINION: In order to improve survival and quality of life, infections of lung transplant patients should be prevented by vaccination. When possible, vaccination should start already during the pre-transplantation period when the patient is on the waiting list. Booster vaccinations should be given post-transplantation, but only when immunosuppression has been tapered. Vaccine design based on mRNA technology could allow the design of an array of vaccines against other respiratory viruses, offering a better protection for lung transplant patients. Twit Text FOAVip Vaccination and their importance for lung transplant recipients in a COVID-19 world ????Expert Rev Clin Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=34328054 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34328054 #FOAvip English Wikipedia <ref>{{Cite pmid|34328054}}</ref> Vaccination and their importance for lung transplant recipients in a COVID-19 world #MMPMID34328054 Scharringa S; Hoffman T; van Kessel DA; Rijkers GT Expert Rev Clin Pharmacol 2021[Nov]; 14 (11): 1413-1425 PMID34328054show ga INTRODUCTION: Lung transplant patients are immunocompromised because of the medication they receive to prevent rejection, and as a consequence are susceptible to (respiratory) infections. Adequate vaccination strategies, including COVID-19 vaccination, are therefore needed to minimize infection risks. AREAS COVERED: The international vaccination guidelines for lung transplant patients are reviewed, including the data on immunogenicity and effectivity of the vaccines. The impact on response to vaccination of the various categories of immunosuppressive drugs, used in the posttransplant period, on response to vaccination is described. A number of immunosuppressive and/or anti-inflammatory drugs also is used for controlling the immunopathology of severe COVID-19. Current available COVID-19 vaccines, both mRNA or adenovirus based are recommended for lung transplant patients. EXPERT OPINION: In order to improve survival and quality of life, infections of lung transplant patients should be prevented by vaccination. When possible, vaccination should start already during the pre-transplantation period when the patient is on the waiting list. Booster vaccinations should be given post-transplantation, but only when immunosuppression has been tapered. Vaccine design based on mRNA technology could allow the design of an array of vaccines against other respiratory viruses, offering a better protection for lung transplant patients. |*COVID-19 Vaccines/classification/immunology/pharmacology[MESH] |*Immunocompromised Host/drug effects/immunology[MESH] |*Lung Transplantation/methods/psychology[MESH] |*Quality of Life[MESH] |*Vaccination/methods/standards[MESH] |COVID-19/epidemiology/*prevention & control[MESH] |Humans[MESH] |Immunogenicity, Vaccine/*immunology[MESH] |Practice Guidelines as Topic[MESH]Vaccination and their importance for lung transplant recipients in a C(epmc).pdf DeepDyve Pubget Overpricing